Literature DB >> 1329737

Expressions of receptor gene for hepatocyte growth factor in kidney after unilateral nephrectomy and renal injury.

K Ishibashi1, S Sasaki, H Sakamoto, Y Hoshino, T Nakamura, F Marumo.   

Abstract

The renal expressions of the receptor gene (c-met) for hepatocyte growth factor (HGF) were examined in unilateral nephrectomy (UNX), renal ischemia or folic acid administration. The levels of c-met mRNA were increased rapidly in all rat models at 6h after the operations. On the other hand, the expression of c-met mRNA in a kidney cell line (MDCK cells) was down-regulated for 8 h after HGF addition, indicating that c-met mRNA induction in rat models may be independent of the stimulated production of HGF. The stimulated expression of c-met in these models suggest that HGF may play an important role in renal hypertrophy after UNX and regeneration after ischemic or nephrotoxic injury.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329737     DOI: 10.1016/0006-291x(92)90465-w

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Expression of HGF mRNA in human rejecting kidney as evidenced by in situ hybridization.

Authors:  K Yamaguchi; M A Nalesnik; G K Michalopoulos
Journal:  Urol Res       Date:  1996

2.  Met activation is required for early cytoprotection after ischemic kidney injury.

Authors:  Sherene Mason; Carlos Hader; Arnaud Marlier; Gilbert Moeckel; Lloyd G Cantley
Journal:  J Am Soc Nephrol       Date:  2013-10-17       Impact factor: 10.121

3.  Unilateral nephrectomy elongates primary cilia in the remaining kidney via reactive oxygen species.

Authors:  Sang Jun Han; Hee-Seong Jang; Jee In Kim; Joshua H Lipschutz; Kwon Moo Park
Journal:  Sci Rep       Date:  2016-02-29       Impact factor: 4.379

Review 4.  Bioactive Compounds for the Treatment of Renal Disease.

Authors:  Kang Su Cho; In Kap Ko; James J Yoo
Journal:  Yonsei Med J       Date:  2018-11       Impact factor: 2.759

5.  Phase 3 trial Design of the Hepatocyte Growth Factor Mimetic ANG-3777 in Renal Transplant Recipients With Delayed Graft Function.

Authors:  Flavio Vincenti; Jim Kim; Deborah Gouveia; Gabrielle Pelle; Tracy J Mayne; John F Neylan
Journal:  Kidney Int Rep       Date:  2020-11-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.